4 / 9
6
t h
A n n u a l E u r o p e a n C o n f e r e n c e o n
Gastroenterology
Journal of Clinical Gastroenterology and Hepatology
ISSN 2575-7733
J u n e 1 9 - 2 0 , 2 0 1 8
P a r i s , F r a n c e
Euro Gastro 2018
Page 21
Mona E Moussa, J Clin Gastroenterol Hepatol 2018, Volume: 2
DOI: 10.21767/2575-7733-C1-001
D
esigner drugs is an informal term for psychoactive drugs that were initially
discovered through the research of, and experimentation upon, the structure
and activity of existing psychoactive drugs. They are created in concealed
locations and/or homemade labs. A designer drug generally mimics the effects
of well-known drugs such as cocaine, morphine or cannabis, by using chemicals
that are legally available on the market. The resulting drugs have similar effects
to the well-known drugs, but their chemical structures are completely different.
Designer drugs can be categorized to three major divisions: (synthetic stimulants)
e.g Mephedrone , (synthetic cannabinoid) e.g. spice, (synthetic hallucinogen) e.g.
foxy methoxy. Their effects are variable depending on the type of drug taken. The
toxicological effects of those drugs are unpredictable owing to the diversity of
the chemicals used and the contaminants which vary between the labs producing
such substances.
Biography
Mona E Moussa has completed her MD and Postdoctoral
studies from Ain Shams University. She is the Chairman of the
Toxicology and Forensic department at Ain Shams University,
one of the eminent universities in Egypt. She is the Director of
Egyptian fellowship program of Clinical Toxicology and Head
of Clinical Toxicology at Helwan University. She has published
more than 80 papers in reputed journals and has been serving
as an Editorial Board Member of repute.
monaelkotbmoussa@med.asu.edu.egDesigner Drugs
Mona E Moussa
Ain Shams University, Egypt